1.Comparison of the Clinical Manifestations, Brain MRI and Prognosis between NeuroBehcet's Disease and Neuropsychiatric Lupus.
Byung Sik CHO ; Hyun Sook KIM ; Su Jin OH ; Hyeok Jae KO ; Chong Hyun YOON ; So Lyung JUNG ; Do June MIN ; Wan Uk KIM
The Korean Journal of Internal Medicine 2007;22(2):77-86
BACKGROUND: Neuropsychiatric systemic lupus erythematosus (NPSLE) shows some similarities to neuroBehcet's disease (NBD) in that both conditions have some analogous clinical features and they are both pathologically associated cerebral vasculopathy. This study compared the clinical manifestations, brain MRI findings and prognosis of NPSLE and NBD patients. METHODS: Forty three patients with NPSLE (n = 25) or NBD (n = 18), who were monitored at a single center, were enrolled in this study. We retrospectively analyzed the clinical and brain MRI data. The neuropsychiatric manifestations were classified in both groups according to the new American College of Rheumatology nomenclature for NPSLE. RESULTS: The diffuse symptoms that included mood disorders, psychosis, confusion, cognitive dysfunctions, generalized seizures and headaches other than migraine or cluster headaches were more commonly observed in the NPSLE patients, while the frequency of focal diseases such as cranial neuropathy tended to be higher in the NBD patients. The brain MRI revealed that the NBD patients had more abnormalities in the brain stem than did the NPSLE patients. Most of the patients improved, at least partially, after being treated with glucocorticoid and/or immune suppressants. However, the disease course differed significantly between the two groups. There were more episodic cases in the NPSLE group of patients, while there were more remittent cases in the NBD group of patients. CONCLUSION: NPSLE had a tendency to cause diffuse neuropsychiatric manifestations, and it has a different predilection of brain lesions compared with NBD. The NBD patients showed a poorer outcome than did the NPSLE patients, suggesting that different therapeutic strategies for the two diseases need to be considered.
Adult
;
Behcet Syndrome/complications/*diagnosis/pathology
;
Brain/*pathology
;
Female
;
Humans
;
Lupus Erythematosus, Systemic/complications/diagnosis/pathology
;
Lupus Vasculitis, Central Nervous System/complications/*diagnosis/pathology
;
*Magnetic Resonance Imaging
;
Male
;
Prognosis
;
Retrospective Studies
;
Risk Factors
2.A meningomyelocele with normal intracranial signs on ultrasound and false-negative amniotic fluid alpha-fetoprotein and acetylcholinesterase.
Chong Hyeok YOON ; Sang Kyu KANG ; Chan Hee JIN ; Moon Sun PARK ; Jeong Hoon RHO
Obstetrics & Gynecology Science 2014;57(3):223-227
Neural tube defects are the major targets of prenatal diagnoses, along with Down syndrome. Prenatal diagnosis of spina bifida is possible at second trimester of gestation through alpha-fetoprotein and acetylcholinesterase biochemistry assays and ultrasound. In particular, the discovery of characteristic intracranial signs on ultrasound leads to a very high diagnosis rate. However, it is rare for spina bifida to present without intracranial signs while also showing normal values of maternal serum alpha-fetoprotein, amniotic fluid alpha-fetoprotein, and acetylcholinesterase. In our hospital, a fetus with spina bifida was delivered at 37+5 weeks' gestation by cesarean section, and was continually followed up over 2 years to date.
Acetylcholinesterase*
;
alpha-Fetoproteins*
;
Amniotic Fluid*
;
Biochemistry
;
Cesarean Section
;
Diagnosis
;
Down Syndrome
;
Female
;
Fetus
;
Humans
;
Meningocele
;
Meningomyelocele*
;
Neural Tube Defects
;
Pregnancy
;
Pregnancy Trimester, Second
;
Prenatal Diagnosis
;
Reference Values
;
Spinal Dysraphism
;
Ultrasonography*
3.Botulinum Toxin Type A for Facial Wrinkles and Benign Masseter Hypertrophy in Korean Patients.
Nark Kyoung RHO ; Hai Sung KIM ; Yoon Seong KIM ; Yun Jin KIM ; Chong Hyeok KIM ; Pok Kee MIN ; Suk Bae SUH ; Kang Seok LEE ; Sang Ju LEE ; Woo Sun LEE ; Hang Rae CHO ; Sung Woo CHOI ; Jae Young HWANG ; Hong Jig KIM
Korean Journal of Dermatology 2010;48(10):823-831
BACKGROUND: The utilization of botulinum toxin has rapidly expanded into various aesthetic applications. Achieving success with the aesthetic use of neurotoxins depends on several factors, including an understanding of the anatomy, the methods of dilution and the injection technique. Any guidelines representing a consensus for aesthetic treatments using botulinum toxin type A (BTA) have not been published in Korea. OBJECTIVE: We wanted to provide consensus recommendations on the treatment of facial wrinkles and benign masseter hypertrophy using BTA in Korean patients. METHODS: A panel of experienced Korean dermatologists was convened to develop a clinical consensus. The clinical consensus was comprised of the recommendations of the panel and the guidelines on general issues, such as the reconstitution and handling of the BTA, the procedural considerations, the dosing and injection-site standardizations, and the prevention and treatment of unwanted effects. Specific recommendations were provided according to the area of treatment, including glabellar lines, horizontal forehead lines, lateral periorbital wrinkles and benign masseter hypertrophy. RESULTS: The recommended final concentration of BTA was 50 units/ml (5 units/0.1 ml) after reconstitution with physiologic saline. For glabellar lines, the members recommend three injection points (a total of 8 units). For forehead wrinkles, the members recommend nine injections in two rows into the frontalis with 1 unit/point. For crow's feet, the members recommend three injections per side (7 units/side) at the lateral part of the orbicularis oculi. For benign masseter hypertrophy, three injections per side (24~30 units/side) were recommended. CONCLUSION: These consensus recommendations will provide a framework for Korean dermatologists who wish to perform safe and efficacious injection of BTA for facial rejuvenation.
Botulinum Toxins
;
Botulinum Toxins, Type A
;
Consensus
;
Foot
;
Forehead
;
Handling (Psychology)
;
Humans
;
Hypertrophy
;
Korea
;
Neurotoxins
;
Rejuvenation
4.Reciprocal Activation of Fibroblast-like Synoviocyte and Type II Collagen-reactive T cell in Rheumatoid Arthritis.
Chong Hyeon YOON ; Mi Kyung PARK ; Mi La CHO ; Hyeok Jae KO ; Kyung Soo PARK ; Wan Uk KIM ; Jun Ki MIN ; Sang Heon LEE ; Yeon Sik HONG ; Sung Hwan PARK ; Chul Soo CHO ; Ho Youn KIM
The Journal of the Korean Rheumatism Association 2004;11(1):25-36
OBJECTIVE: To investigate the interaction between type II collagen (CII)-reactive T cell and fibroblast-like synoviocyte in rheumatoid arthritis (RA). METHODS: Peripheral blood T cells from RA patients were cultured with bovine CII and analyzed by flow cytometry. After co-culture with CII-reactive T cells and fibroblast-like synoviocytes (FLS), the expression of cytokines (IL-15 and TNF-alpha from FLS, IFN-gamma and IL-17 from CII-reactive T cells) were determined by ELISA and RT-PCR. RESULTS: CII-reactive T cells expressed CD69, one of the early activation markers, and produced significant amount of IFN-gamma, and proliferated. IL-15 and TNF-alpha expression from FLS were significantly elevated when co-culture with CII-reactive T cells and inhibited by physical interruption of cell-to-cell contact or anti-CD40 antibody. IFN-gamma and IL-17 expression from CII-reactive T cells were also significantly elevated when co-culture with FLS and inhibited by anti-IL-15 monoclonal antibody. CONCLUSIONS: CII-reactive T cells can activate FLS to secret proinflammatoy cytokines and interactions between these two cells drive further activation of each other. These data suggest that CII-reactive T cell may play a important role in pathogenesis of RA.
Arthritis, Rheumatoid*
;
Coculture Techniques
;
Collagen Type II
;
Cytokines
;
Enzyme-Linked Immunosorbent Assay
;
Flow Cytometry
;
Humans
;
Interleukin-15
;
Interleukin-17
;
T-Lymphocytes
;
Tumor Necrosis Factor-alpha